Connect with us
Rare diseases are, despite advances, an important area of development for biomedical research, since only 5% of these pathologies have an available treatment. However, current European...
This year, one of the main headaches for managers in the sector will be inflation. GSK and Novartis plan to carry out a double-digit price increase...
AstraZeneca has agreed to acquire CinCor Pharma in a deal that could exceed $1 billion. CinCor Pharma develops treatments for resistant hypertension and chronic kidney disease,...
Onalabs, a biotechnological start-up specializing in digital devices for chronic patients, has created a subsidiary in Andorra. Through two pilot programs in the principality, the Ona...
Pharma Mar has decided to liquidate its diagnostic subsidiary Genomics, as part of their strategy to focus on their core activity of drug development and marketing....
Moderna has made the announcement of new vaccines with its mRNA technology. In addition to Covid-19, the company is working with Merck on a skin cancer vaccine...
On July 13th, 2022, the new call for the granting of subsidies for the year to Personalized Precision Medicine Research Projects for €81.5 million was published. Likewise,...
The help of EIC Accelerator will allow Gate2Brain to boost its proprietary technology based on peptides (small proteins) that cross biological barriers and reach the brain....
The Ministry will launch a national open science strategy, with support for institutions to publish their research in the open, as well as data, methods, or...
Indra will go through three phases of the project. For the start-up, a master plan will be carried out during the first two weeks, in order to...
 |
|
 |  |
 |
|